Cargando…
Value of incorporating newly identified risk factors into risk prediction for chemotherapy‐induced febrile neutropenia
Several comorbidities have recently been shown to affect risk of chemotherapy‐induced febrile neutropenia (FN). Here, we evaluated the added predictive value of these comorbidities beyond established FN risk factors. A retrospective cohort study was conducted among adult patients diagnosed with canc...
Autores principales: | Li, Yanli, Family, Leila, Chen, Lie H., Page, John H., Klippel, Zandra, Xu, Lanfang, Chao, Chun R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089155/ https://www.ncbi.nlm.nih.gov/pubmed/29953736 http://dx.doi.org/10.1002/cam4.1580 |
Ejemplares similares
-
Risk stratification for febrile neutropenia in patients with testicular germ cell tumors
por: Terbuch, Angelika, et al.
Publicado: (2018) -
The risk of early mortality in elderly patients with newly diagnosed acute myeloid leukemia
por: Liu, Chia‐Jen, et al.
Publicado: (2020) -
Risk prediction model for lung cancer incorporating metabolic markers: Development and internal validation in a Chinese population
por: Lyu, Zhangyan, et al.
Publicado: (2020) -
Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV‐16/18 antibodies
por: Rosillon, Dominique, et al.
Publicado: (2019) -
Assessing patients’ risk of febrile neutropenia: is there a correlation between physician-assessed risk and model-predicted risk?
por: Lyman, Gary H, et al.
Publicado: (2015)